Clinical trials show progress in migraine frequency, skin cancer prevention
-
2:45
Closing arguments begin in trial of Harry Wait
-
2:15
New Marquette Law School Poll reveals voters undecided about...
-
2:12
Milwaukee city attorney ’changes mind’ on piece of ’ICE...
-
3:51
Aurora Health Care doctor discusses colorectal cancer
-
1:01
Potawatomi Casino Hotel CEO calls on Evers to sign bill legalizing...
-
2:01
Common Council delays confirmation of Karin Tyler as new director...
-
0:47
Evers’ administration celebrates Women’s History Month with...
-
0:59
’Not about protecting democracy’: Community leaders express...
-
1:18
Milwaukee Film Festival preview includes look at ’The Big Cheese,’...
-
3:13
WisDOT joins CBS 58 to talk I-94 traffic as road work continues...
-
1:46
The North Shore Library starts a new chapter in Bayside
-
6:03
Milwaukee magicians celebrate Houdini’s birthday, preview upcoming...
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.